Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1387-1393

  Gross, Nicole ^a   Balmas, Katia ^a   Brognara, Christine Beretta ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; ONCOGENE C MYB; PRIORITY JOURNAL;

ANTIBODIES, BLOCKING; ANTIGENS, CD44; CELL ADHESION; COLLAGEN; FIBRONECTINS; GENES, MYC; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; LAMININ; NEUROBLASTOMA; TIME FACTORS; TRANSFECTION; TUNICAMYCIN;

EID: 0031000907     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Picker, L. J., De Los Toyos, J., Telen, M. J., Haynes, B. F., and Butcher, E. C. Monoclonal antibodies against the CD44 (In(Lu)-related P80) and Pgp-1 antigens in man recognize the Hermes class of lymphocyte-homing receptors. J. Immunol., 142: 2046-2051, 1989.
2. Goldstein, L. A., Zhou, D. F. H., Picker, L. J., Minty, C. N., Bargatze, R. F., Ding, J. F., and Butcher, E. C. A human lymphocyte homing receptor, the Hermes antigen is related to cartilage proteoglycan core and link proteins. Cell, 56: 1063-1072, 1989.
3. Brown, T. A., Bouchard, T., St John, T., Wayner, E., and Carter, W. G. Human Keratinocytes express a new CD44 core protein (CD44E) as a heparan sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol., 113: 207-221, 1991.
4. Underhill, C. B. CD44: The hyaluronan receptor. J. Cell Sci., 103: 293-298, 1992.
5. Stamenkovic, I., Amiot, M., Pesando, J. M., and Seed, B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell, 56: 1057-1062, 1989.
6. Screaton, G. R., Bell, M. V., Jackson, D. J., Cornelis, F. B., Gerth, U., and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA, 89: 12160-12164, 1992.
7. Myiake, K., Underhill, C. B., Lesley, J., and Kincade P. W. Hyaluronate can function as a cell adhesion molecule and CD44 participate in hyaluronate recognition. J. Exp. Med., 172: 69-75, 1990.
8. Stamenkovic, I., Aruffo, A., Amiot, M., and Seed, B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10: 343-348, 1991.
9. Thomas, L., Etoh, T., Stamenkovic, I., Mihm, M. C., and Byers, H. R. Migration of human melanoma cells on hyaluronate is related to CD44 expression. J. Invest. Dermatol., 100: 115-120, 1993.
10. St John, T. J., Meyer, J., Idzerda, R., and Gallatin, W. M. Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell, 60: 45-00, 1990.
11. Haynes, B. F., Telen, M. J., Hale, L. P., and Denning, S. M. CD44 a molecule involved in leukocyte adherence and T cell activation. Immunol. Today, 10: 423-427, 1989.
12. Bartolazzi, A., Peach, R., Aruffo, A., and Stamenkovic, I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180: 53-66, 1994.
13. Günthert, U., Hofmann, M., Rudy W., Reber, S., Zöller, M., Haussman, I., Matsku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
14. Stamenkovic, I., Aruffo, A., Amiot, M., and Seed, B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10: 343, 1991.
15. Sy, M. S., Guo, Y. J., and Stamenkovic, I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med., 174: 859-863, 1991,
16. Lesley, J., Hyman, R., and Kincade, P. CD44 and its interaction with the extracellular matrix. Adv. Immunol., 54: 271-335, 1993.
17. Aruffo, A., Stamenkovic, I., Melnick, M., Underbill, C. B., and Seed, B. CD44 is the principal receptor for hyaluronate. Cell, 61: 1303-1313, 1990.
18. Quackenbush, E. J., Vera, S., Greaves, A., and Letarte, M. Confirmation by peptide sequence and co-expression on various cell types of the identity of CD44 and p85 glycoprotein. Mol. Cell Immunol. 10: 947, 1990.
19. Hofmann, M., Rudy, W., Zöller, M., Tölg, C., Ponta, H., Herrlich, P., and Günthert, U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51: 5292-5297, 1991.
20. Liao, H-X., Levesque, M. C., Patton, K., Bergamo, B., Jones, D., Moody, M. A., Telen, M. J., and Haynes, B. F. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol., 151: 6490-6499, 1993.
21. Murakami, S., Shimabukuro, Y., Miki, Y., Saho, T., Hino, E., Kasai, D., Nozaki, T., Kusumoto, Y., and Okada, H. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J. Immunol., 152: 467-477, 1994.
22. Hathcock, K. S., Hirano, H., Murakami, S., and Hodes, R. J. CD44 expression on activated B cells. J. Immunol., 151: 6712-6722, 1993.
23. Lesley, J., English, N., Perschl, A., Gregoroff, J., and Hyman, R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med., 182: 431-437, 1995.
24. Bennett, K. L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D. G., Spring F., and Aruffo, A. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol., 131: 1623-1633, 1996.
25. Asplund, T., and Heldin, P. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cell. Cancer Res., 54: 4516-4523, 1994.
26. Hyman, R., Lesley, J., and Schulte, R. Somatic cell mutants distinguish CD44 expression and hyaluronic binding. Immunogenetics, 33: 343-348, 1991.
27. Evans, A. E. Natural history of neuroblastoma. In: A. E. Evans (ed.), Advances in Neuroblastoma Research, pp. 3-12. New York: Raven Press, 1980.
28. Brodeur, G. M., Azar, C., and Brother, M. Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer (Phila.), 70: 1685-1692, 1992.
29. Schwab, M., Varmus, H. E., and Bishop, J. M. Human N-myc gene contributes to the neoplastic transformation of mammalian cells in culture. Nature (Lond), 316: 160-162, 1985.
30. Gross, N., Beretta, C., Peruisseau, G., Jackson, D., Simmons, D., and Beck, D. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res., 54: 4238-4242, 1994.
31. Favrot, M. C., Combaret, V., and Lasset, C. CD44: a new prognostic marker for neuroblastoma. N. Engl. J. Med., 329: 1965, 1993.
32. Combaret, V., Gross, N., Lasset, C., Frappaz, D., Perruisseau, G., Philip, T., Beck, D., and Favrot, M. Clinical relevance of CD44 cell surface expression and NMYC gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J. Clin. Oncol., 14: 25-34, 1996.
33. Gross, N., Miescher, G., Beck, D., Favre, S., and Beretta, C. Altered growth and phenotype in clonal MYCN transfectants of the SK-N-SH neuroblastoma cell line. Int. J. Cancer, 59: 141-148, 1994.
34. Gross, N., Beck, D., Beretta, C., Jackson, D., and Perruisseau, G. CD44 expression and modulation on human neuroblastoma tumours and cell lines. Eur. J. Cancer, 31: 471-475, 1995.
35. Suardet, L., Gross, N., Gaide, A-L., Beck D., and Eliason, J. F. Epidermal growth factor responsiveness of a new neuroblastoma cell line. Int. J. Cancer, 44: 661-668, 1989.
36. Gross, N., Carrel, S., Beck, D., and Favre, S. Cell adhesion molecules expression and modulation on human neuroblastoma cells. Prog. Clin. Biol. Res., 366: 293-299, 1991.
37. Dalchau, R., Kirkley, R., and Fabre, J. W. Monoclonal antibody to a human brain-granulocyte T lymphocyte antigen probably homologous to the W3/13 antigen of the rat. Eur. J. Immunol., 10: 745-749, 1980.
38. Jalkanen, S., and Jalkanen, M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol., 116: 817-825, 1992.
39. Prater, C. A., Plotkin, J., Jaye, D., and Frazier, W. A. The properdin-like type 1 repeats of human thrombospondin contain a cell attachment site. J. Cell Biol., 112: 1031-1040, 1991.
40. Takahashi, K., Stamenkovic, I., Cutler, M., Dasgupta, A., and Tanabe, K. K. Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J. Biol. Chem., 277: 9490-9496, 1996.
41. Katoh, S., Zheng, Z., Oritani, K., Shimozato, T., and Kincade, P. W. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med., 182: 419-429, 1995.
42. Bartolazzi, A., Nocks, A., Aruffo, A., Spring, F., and Stamenkovic, I. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol., 132: 1199-1208, 1996.
43. Puré, E., Camp, R. L., Peritt, D., Panettieroi, R. A., Aili, Jr., Lazaar, L., and Nayak, S. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med., 181: 55-62, 1995.
44. Toole, B. P., Biswas C., and Gross, J. Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc. Natl. Acad. Sci. USA, 76: 6299-6303, 1979.
45. Zhang, L., Underbill, C. B., and Chen, L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res., 55: 428-433, 1995.
46. Knudson, C. B., and Knudson, W. Similar epithelial-stromal interactions in the regulation of hyaluronate production during limb morphogenesis and tumor invasion. Cancer Lett., 52: 113, 1990.
47. Lokeshwar, V. B., and Bourguignon L. Y. W Post-translational modification and expression of ankyrin-binding sites in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T lymphoma membrane biosynthesis. J. Biol. Chem., 266: 17983-17989, 1991.